ci 988 has been researched along with niacinamide in 1 studies
Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (niacinamide) | Trials (niacinamide) | Recent Studies (post-2010) (niacinamide) |
---|---|---|---|---|---|
147 | 8 | 14 | 13,381 | 1,097 | 5,797 |
Protein | Taxonomy | ci 988 (IC50) | niacinamide (IC50) |
---|---|---|---|
Chain A, NAD-dependent deacetylase | Thermotoga maritima | 1000 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 3.3 | |
NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 2.9 | |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Homo sapiens (human) | 8.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bickerdike, MJ; Dourish, CT; Fletcher, A; Marsden, CA | 1 |
1 other study(ies) available for ci 988 and niacinamide
Article | Year |
---|---|
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Devazepide; Diazepam; Indoles; Male; Maze Learning; Meglumine; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Rats; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors; Zimeldine | 1994 |